Additive growth-inhibitory effects of DL-α-difluoromethylornithine and antiestrogens on MCF-7 breast cancer cell line
- 1 November 1987
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 148 (3), 1338-1345
- https://doi.org/10.1016/s0006-291x(87)80279-6
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Chemotherapeutic implications of polyamine biosynthesis inhibitionClinical Pharmacology & Therapeutics, 1984
- Reversal of the Antiproliferative Effect of the Antiestrogen Tamoxifen by Polyamines in Breast Cancer Cells*Endocrinology, 1984
- Effects of a new antiestrogen, keoxifene (LY156758), on growth of carcinogen-induced mammary tumors and on LH and prolactin levelsLife Sciences, 1983
- Differential interaction of antiestrogens with cytosol estrogen receptorsMolecular and Cellular Endocrinology, 1981
- Uterine bioassay of tamoxifen, trioxifene and a new estrogen antagonist (LY117018) in rats and miceLife Sciences, 1980
- Tamoxifen in advanced breast cancerCancer Treatment Reviews, 1978
- Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C.4.1.1.17) by substrate and product analogsJournal of the American Chemical Society, 1978
- Tamoxifen (Antiestrogen) Therapy in Advanced Breast CancerAnnals of Internal Medicine, 1977
- Estrogenic Induction of Ornithine Decarboxylase in vivo and in vitroScience, 1970
- A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acidBiochemical Journal, 1956